- US12157737utility2024Heteroaryl Substituted Spiropiperidinyl Derivatives and Pharmaceutical Uses Thereof0 cites
- US12145909utility2024N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole Negative Allosteric Modulators of NR2B0 cites
- US12146187utility2024Methods of Treating Dry Eye Disease Using TNF Alpha Antagonists0 cites
- US12139471utility2024NLRP3 Inflammasome Inhibitors0 cites
- US12134611utility2024Compounds and Compositions for Treating Conditions Associated with NLRP Activity0 cites
- US12128069utility2024Treatment of Cancer Using Chimeric Antigen Receptor and Protein Kinase a Blocker0 cites
- US12129246utility2024Hydroquinazoline Derivatives for the Treatment of a Disease or Disorder0 cites
- US12122761utility20242-azaspiro[3.4]octane Derivatives as M4 Agonists0 cites
- US12103919utility20243-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and Uses Thereof0 cites
- US12090125utility2024Combination Therapy0 cites
- US12091424utility2024Rapamycin Derivatives0 cites
- US12083101utility2024Biaryl Derivatives as YAP/TAZ-TEAD Protein-protein Interaction Inhibitors0 cites
- US12084424utility2024Compounds and Compositions for Treating Conditions Associated with NLRP Activity0 cites
- US12084442utility2024Naphthyridinone Derivatives for the Treatment of a Disease or Disorder0 cites
- US12084460utility2024Crystalline Forms of a TLR7/TLR8 Inhibitor0 cites
- US12077571utility2024Polyomavirus Neutralizing Antibodies0 cites
- US12077580utility2024Anti-il-17a Antibodies and Their Use in Treating Autoimmune and Inflammatory Disorders0 cites
- US12071402utility2024Immunosuppressant Formulations0 cites